Bio-Rad Laboratories, Inc. (BIO.B) fundamentals chart

BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value

$379.50+0.00 (0.00%)

Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –

Fundamental chart

Pick a measure to chart its full history

$2.58BFY2025, +1.6% a year since FY2011

Parsed from the XBRL in Bio-Rad Laboratories's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Mar 8, 2002
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BIO.B.

Revenue growth1.4% · median 4.1%

Gross margin51.9% · median 46.4%

Operating margin2.1% · median 3.1%

Net margin8.6% · median 3.6%

Advertisement
300 × 250